While COVID-19 trends in Arizona continue to improve, a new report shows the state has the highest rate of children and young adults 19 and under testing positive for the infection. A number of late-stage clinical trials are underway in Arizona to test drugs for possible COVID-19 treatments while vaccine clinical trials continue as well. The COVID-19 pandemic could be having health impacts well beyond an infection. Banner Health reports a dramatic drop in cancer screenings and diagnoses as people are likely delaying care.
Could one of these drugs be the next emergency treatment for COVID-19? / Arizona Republic
Arizona has highest rate of pediatric COVID-19 in the US, report says / Arizona Republic
New reports find Arizona at the top for kids testing positive for COVID-19 / 12 News
Improving Arizona COVID-19 trends could drive testing declines, complacency / KJZZ
COVID-19 cases are falling in Arizona, but risk level remains high / Arizona Daily Star
COVID-19 tests in Arizona dropped dramatically in July. Here’s why that’s an issue / Arizona Republic
Race for protection underway as coronavirus vaccine trials continue in Arizona / ABC 15
Pediatricians urge Arizona families not to skip childhood vaccines during COVID-19 / Arizona Republic
Arizona doctor: Cancer diagnoses down during COVID-19 pandemic / azfamily.com
Banner Health reports drop in cancer diagnoses during virus pandemic / KTAR
ASU, UA And NAU outline plans for fall reopening / KJZZ
TGen study of U.S. Navy dolphins offers clues to human aging / KJZZ
Researchers from the Translational Genomics Research Institute and partners have found biomarkers in dolphins that could help explain why some animals, including humans, age faster and develop more age-related diseases than others.
UA prof’s invention saving sight of cataract patients worldwide / Arizona Daily Star
Technology for a new kind of trifocal lens implant developed by a University of Arizona professor to help cataract patients see clearly has been used in more than 500,000 patients overseas and was approved for use in the U.S. last fall.